CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Prospective clinical validation of an assay for methylated SEPT9 DNA for use in detection of colorectal cancer in human plasma from average risk men and women over the age of 50
DOI 10.1055/s-0030-1263603
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Church, T Rösch, M Wandell, E Heiden, C Lofton-Day, M Burger, D Ransohoff
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: A suitably sensitive and specific blood-based test for colorectal cancer (CRC) could appreciably increase the number of guideline eligible average risk individuals screened due to increased convenience and safety compared to other screening methods. Two previous case-control studies of clinically confirmed CRC demonstrated that detection of methylated SEPT9 DNA (mSEPT9) in plasma indicated the presence of CRC.…
Zitieren
Zitierempfehlung
T Church, T Rösch, M Wandell, E Heiden, C Lofton-Day, M Burger, D Ransohoff (2010) Prospective clinical validation of an assay for methylated SEPT9 DNA for use in detection of colorectal cancer in human plasma from average risk men and women over the age of 50. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0030-1263603
Mit CareLit weiterarbeiten